US chip-packaging plans need matching production milestones

Original research record

What’s changing? We connect two reports in OTR Database Data: one records a new manufacturing agreement; the other separates its long lead time from current output. We then check the separate packaging and testing plans. An interposer is a connecting layer inside a chip package. Our inference is that buyers gain a usable alternative supply route only when the required parts, assembly and tests work together for their product.

Key points We distinguish a manufacturing agreement from money spent on building a factory. We check component production, assembly, testing and customer approval as separate milestones. We treat Amkor’s later phase as extra capacity. Its end-2029 target does not mean all US packaging must wait until then. We have no verified route showing GlobalFoundries components going to Amkor for a named customer product.

What could change this view? Verified production milestones and customer approval for a named domestic route would strengthen our view. Delays, poor manufacturing results or cancelled demand would weaken it. A proven alternative route could also reduce the importance of either proposed site.

Bottom line We would judge progress by a dated product-level record: which component is ready, where it is assembled and tested, and when the customer approves it. Larger budgets and signed agreements strengthen the plan; they do not measure completed output.

How likely is this call? · Three frameworks This signal has no investible bullish or bearish call. A market-direction percentage does not apply. Bayesian · what changed the estimate? We now have a specific interposer manufacturing agreement to compare with the separate assembly and testing plans. This strengthens the reason to examine a domestic route, but we have no fitted prior, likelihood or numerical probability. Customer-approved production would provide stronger evidence. de Finetti · are the comparisons fair? We keep different manufacturing stages, customer products and construction phases separate. The companies share commercial ties through TSMC, so their releases are not independent success trials. Reprints and translated versions of the same announcement remain one source event. No comparable-case sample has been established. Kolmogorov · do the numbers agree? We make no defined market-return prediction. Bullish, bearish and neutral percentages, a neutral price band, entry price and market deadline are not applicable. We do not add a contract value to a campus investment budget or treat an expansion date as the start of every production line. Against this view: existing and alternative production routes may already meet customer needs. What changes it: verified product milestones and customer approval. Horizon and price basis: Not applicable. Research gaps: product routing, manufacturing yields, capacity by stage and customer delivery records. Sources: the linked company releases and technical records. Read the shared method: https://new.ontherice.org/how-otr-works/#probability-framework.

Evidence behind this view We checked [GlobalFoundries’ 8 October announcement](https://gf.com/news-and-events/news/globalfoundries-reaches-agreement-to-establish-us-based-supply-of-silicon-interposers-for-advanced-ai-packaging/): a US$2 billion agreement with TSMC, initially lasting five years, with volume production expected to start ramping in Malta, New York, in the first half of 2028. Separately, the [16 June Amkor–TSMC agreement](https://ir.amkor.com/news-releases/news-release-details/tsmc-and-amkor-technology-announce-long-term-partnership) sets a ten-year framework for packaging and testing services. Amkor’s [8 September update](https://ir.amkor.com/news-releases/news-release-details/amkor-technology-announces-phase-2-arizona-advanced-packaging) puts planned total campus investment at about US$12 billion; its second phase is expected to start construction in late 2027 and finish by end-2029. These are distinct commitments and cost measures. We do not add them into one investment total.

What past price moves show Not applicable: we make no market-price call. We have no matched historical sample that estimates how these particular factory plans will change delivery time, supply resilience or returns.

Evidence against this view We have not verified customer-approved output from these planned US additions. Amkor’s [earlier construction notice](https://ir.amkor.com/news-releases/news-release-details/amkor-technology-breaks-ground-new-semiconductor-advanced) targeted initial production in early 2028, so phase two is not the start date for its whole campus. Existing overseas facilities can also serve customers. [TSMC describes several package designs](https://3dfabric.tsmc.com/english/dedicatedFoundry/technology/cowos.htm), so we cannot assume one component or factory is essential to every product. Announced dates may change, and no reviewed source establishes a direct GlobalFoundries-to-Amkor product route.

Why the direction changed We make no market-direction change and alter no earlier forecast. This is a new cross-file synthesis about separate manufacturing stages and their delivery dates. Later milestones should be dated updates, with this record preserved.

What people say vs the facts We have no representative sample of public opinion. Company statements show plans and commercial interest. We would test claims about domestic supply security against named products, customer approval and delivered volume.

How past forecasts performed We have no resolved forecast sample for this particular supply-chain plan. We cannot turn the number of agreements, factory area or announced dollars into a measured chance of success.